198 related articles for article (PubMed ID: 31626211)
1. [Molecular genetic markers and criteria for the prediction of adrenocortical carcinoma].
Selivanova LS; Roslyakova AA; Bogolyubova AV; Tertychnyi AS; Beltsevich DG; Abrosimov AY; Melnichenko GA
Arkh Patol; 2019; 81(5):92-96. PubMed ID: 31626211
[TBL] [Abstract][Full Text] [Related]
2. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.
Sbiera S; Schmull S; Assie G; Voelker HU; Kraus L; Beyer M; Ragazzon B; Beuschlein F; Willenberg HS; Hahner S; Saeger W; Bertherat J; Allolio B; Fassnacht M
J Clin Endocrinol Metab; 2010 Oct; 95(10):E161-71. PubMed ID: 20660055
[TBL] [Abstract][Full Text] [Related]
3. Genomic and expression profiling of adrenocortical carcinoma: application to diagnosis, prognosis and treatment.
Bussey KJ; Demeure MJ
Future Oncol; 2009 Jun; 5(5):641-55. PubMed ID: 19519204
[TBL] [Abstract][Full Text] [Related]
4. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis.
Tömböl Z; Szabó PM; Molnár V; Wiener Z; Tölgyesi G; Horányi J; Riesz P; Reismann P; Patócs A; Likó I; Gaillard RC; Falus A; Rácz K; Igaz P
Endocr Relat Cancer; 2009 Sep; 16(3):895-906. PubMed ID: 19546168
[TBL] [Abstract][Full Text] [Related]
5. Adrenocortical carcinoma (ACC): When and why should we consider germline testing?
Petr EJ; Else T
Presse Med; 2018; 47(7-8 Pt 2):e119-e125. PubMed ID: 30104051
[TBL] [Abstract][Full Text] [Related]
6. Adrenocortical carcinoma and succinate dehydrogenase gene mutations: an observational case series.
Else T; Lerario AM; Everett J; Haymon L; Wham D; Mullane M; Wilson TL; Rainville I; Rana H; Worth AJ; Snyder NW; Blair IA; McKay R; Kilbridge K; Hammer G; Barletta J; Vaidya A
Eur J Endocrinol; 2017 Nov; 177(5):439-444. PubMed ID: 28819017
[TBL] [Abstract][Full Text] [Related]
7. Pathological and molecular features of adrenocortical carcinoma: an update.
Volante M; Buttigliero C; Greco E; Berruti A; Papotti M
J Clin Pathol; 2008 Jul; 61(7):787-93. PubMed ID: 18430754
[TBL] [Abstract][Full Text] [Related]
8. PERSONALIZED CARE OF PATIENTS WITH ADRENOCORTICAL CARCINOMA: A COMPREHENSIVE APPROACH.
Miller BS; Else T;
Endocr Pract; 2017 Jun; 23(6):705-715. PubMed ID: 28614035
[TBL] [Abstract][Full Text] [Related]
9. Candidate diagnostic markers and tumor suppressor genes for adrenocortical carcinoma by expression profile of genes on chromosome 11q13.
Fernandez-Ranvier GG; Weng J; Yeh RF; Shibru D; Khafnashar E; Chung KW; Hwang J; Duh QY; Clark OH; Kebebew E
World J Surg; 2008 May; 32(5):873-81. PubMed ID: 18324346
[TBL] [Abstract][Full Text] [Related]
10. Genetics of tumors of the adrenal cortex.
Bonnet-Serrano F; Bertherat J
Endocr Relat Cancer; 2018 Mar; 25(3):R131-R152. PubMed ID: 29233839
[TBL] [Abstract][Full Text] [Related]
11. Expression profiles analysis identifies the values of carcinogenesis and the prognostic prediction of three genes in adrenocortical carcinoma.
Gao Z; Man X; Li Z; Bi J; Liu X; Li Z; Zhu Y; Zhang Z; Kong C
Oncol Rep; 2019 Apr; 41(4):2440-2452. PubMed ID: 30816525
[TBL] [Abstract][Full Text] [Related]
12. Genomic stratification and liquid biopsy in a rare adrenocortical carcinoma (ACC) case, with dual lung metastases.
McCabe MJ; Pinese M; Chan CL; Sheriff N; Thompson TJ; Grady J; Wong M; Gauthier MA; Puttick C; Gayevskiy V; Hajdu E; Wong SQ; Barrett W; Earls P; Lukeis R; Cheng YY; Lin RCY; Thomas DM; Watkins DN; Dinger ME; McCormack AI; Cowley MJ
Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30936196
[TBL] [Abstract][Full Text] [Related]
13. Adrenocortical carcinoma survival rates correlated to genomic copy number variants.
Stephan EA; Chung TH; Grant CS; Kim S; Von Hoff DD; Trent JM; Demeure MJ
Mol Cancer Ther; 2008 Feb; 7(2):425-31. PubMed ID: 18281524
[TBL] [Abstract][Full Text] [Related]
14. Molecular markers and targeted therapies for adrenocortical carcinoma.
Xu Y; Qi Y; Zhu Y; Ning G; Huang Y
Clin Endocrinol (Oxf); 2014 Feb; 80(2):159-68. PubMed ID: 24304415
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of adrenocortical carcinomas.
Soon PS; Sidhu SB
Minerva Endocrinol; 2009 Jun; 34(2):137-47. PubMed ID: 19471238
[TBL] [Abstract][Full Text] [Related]
16. Dissecting Morphological and Molecular Heterogeneity in Adrenocortical Carcinoma.
Duregon E; Volante M; Rapa I; Vatrano S; Papotti M
Turk Patoloji Derg; 2015; 31 Suppl 1():98-104. PubMed ID: 26177320
[TBL] [Abstract][Full Text] [Related]
17. Adrenocortical cancer treatment.
Patalano A; Brancato V; Mantero F
Horm Res; 2009 Jan; 71 Suppl 1():99-104. PubMed ID: 19153517
[TBL] [Abstract][Full Text] [Related]
18. [Childhood adrenocortical tumors: from a clinical to a molecular approach].
Antonini SR; Colli LM; Ferro L; Mermejo L; Castro Md
Arq Bras Endocrinol Metabol; 2011 Nov; 55(8):599-606. PubMed ID: 22218442
[TBL] [Abstract][Full Text] [Related]
19. [Adrenocortical carcinoma: modern concepts of morphological diagnosis and classification].
Urusova LS; Kletskaya IS; Porubayeva EE; Beltsevich DG
Arkh Patol; 2023; 85(4):32-38. PubMed ID: 37530188
[TBL] [Abstract][Full Text] [Related]
20. Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis.
Papathomas TG; Duregon E; Korpershoek E; Restuccia DF; van Marion R; Cappellesso R; Sturm N; Rossi G; Coli A; Zucchini N; Stoop H; Oosterhuis W; Ventura L; Volante M; Fassina A; Dinjens WN; Papotti M; de Krijger RR
Hum Pathol; 2016 Dec; 58():113-122. PubMed ID: 27589897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
